|
Faculty Disclosures
Michael A. Pfaller, MD has disclosed that he has received research support from Astellas Pharma Inc., Merck & Co., Inc., Pfizer, Inc., and Schering-Plough Corporation. He has participated as a speaker and acted as a consultant for Astellas Pharma Inc., Merck & Co., Inc., Pfizer, Inc., and Schering-Plough Corporation.
Kieren A. Marr, MD has disclosed that she has received research support from Associates of Cape Cod, Inc. and Astellas Pharma Inc. She acts as a consultant for Astellas Pharma Inc., Basilea Pharmaceuticals, Enzon Pharmaceuticals, Nektar Therapeutics, Pfizer, Inc., and Schering-Plough Corporation.
Raoul Herbrecht, MD has disclosed that he has received research support from Pfizer Inc. and acts as a consultant for Astellas Pharma Inc., Gilead Sciences, Merck Sharp & Dohme Ltd., Pfizer Inc., Schering-Plough Corporation. He has participated as a speaker for Gilead Sciences, Pfizer, Schering-Plough Corporation, and Zeneus Pharma.
Michael Barnish, DO, Peer Reviewer, Garden State Infectious Disease Associates has disclosed that he does not have any relevant financial relationships with any commercial interests.
| 
